Lysine and Bumetanide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lysine (lysine) and Bumetanide (bumetanide). Common drug interactions include bacteraemia among females and infection among males.

The phase IV clinical study analyzes what interactions people have when they take Lysine and Bumetanide. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Lysine?

Lysine has active ingredients of lysine. It is often used in herpes labialis (oral herpes simplex). eHealthMe is studying from 16,524 Lysine users. Check the latest studies of Lysine.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 24, 2026

23 people who take Lysine and Bumetanide together, and have interactions are studied.

Lysine and Bumetanide drug interactions.

What are the common drug interactions of Lysine and Bumetanide, by gender? *:

female:

  1. Bacteraemia (presence of bacteria in the blood)
  2. Dyspnoea (difficult or laboured respiration)
  3. Parainfluenzae virus infection
  4. Thrombosis (formation of a blood clot inside a blood vessel)
  5. Arthralgia (joint pain)
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Circulatory collapse
  8. Complication of device insertion
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Fall

male:

  1. Infection
  2. Atrophic vulvovaginitis (inflammation of the vulva)
  3. Pulmonary mass
  4. Spinal fracture (fracture in one of vertebrae)
  5. Altered state of consciousness (altered state of mind)
  6. Cyst (a closed sac)
  7. Death
  8. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  9. Faeces discoloured
  10. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

What are the common drug interactions of Lysine and Bumetanide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Hyperkalaemia (damage to or disease of the kidney)
  3. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Oedema (fluid collection in tissue)
  6. Renal failure (kidney dysfunction)

40-49:

n/a

50-59:

  1. Bacteraemia (presence of bacteria in the blood)
  2. Dyspnoea (difficult or laboured respiration)
  3. Parainfluenzae virus infection
  4. Thrombosis (formation of a blood clot inside a blood vessel)
  5. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  6. Leukocytosis (increased white blood cells)
  7. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  8. Renal transplant
  9. Thrombocytopenia (decrease of platelets in blood)

60+:

  1. Fall
  2. Diarrhoea
  3. Foot deformity (functional disability of foot)
  4. Gait disturbance
  5. Hyperhidrosis (abnormally increased sweating)
  6. Impaired healing
  7. Limb asymmetry (consistent task discrepancy between the two lower limbs)
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  10. Asthma

What are the existing conditions these people have? *

  1. Pain: 7 people, 30.43%
  2. High Blood Pressure: 6 people, 26.09%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 17.39%
  4. Hair Loss: 4 people, 17.39%
  5. Immune System Disorder: 4 people, 17.39%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 13.04%
  7. Constipation: 3 people, 13.04%
  8. Nausea (feeling of having an urge to vomit): 3 people, 13.04%
  9. Indigestion: 3 people, 13.04%
  10. Type 2 Diabetes: 3 people, 13.04%

* Approximation only. Some reports may have incomplete information.

Do you take Lysine and Bumetanide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lysine and Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lysine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lysine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bumetanide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lysine and bumetanide (the active ingredients of Lysine and Bumetanide, respectively), and Lysine and Bumetanide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: